EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Anti-Hepatitis B Virus Activity of Hydroxytyrosol from Lindernia ruellioides

Tong-Shi-Yao Zhao, Kang-Zhi Li, He-Ling Su, Bin Liang, Cheng-Qin Liang, Jin-Tao Gao iD, Xian-Li Zhou iD

Molecules · 2025

DOI: 10.3390/molecules30092063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Tong-Shi-Yao Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Medical Engineering, Education Department of Guangxi Zhuang Autonomous Region, Guilin Medical University, Guilin 541100, …. Hauptthemen laut MEDLINE: Hepatitis B virus, Phenylethyl Alcohol, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B is a serious infectious disease that threatens the health of all mankind. In this study, we isolated and extracted hydroxytyrosol from Lindernia ruellioides with anti-hepatitis B virus (HBV) activity. The structure of hydroxytyrosol was identified by the nuclear magnetic resonance technique. HepG2.2.15 cell models were used to detect the anti-HBV activity and liver protection of hydroxytyrosol in vitro. Hydroxytyrosol can inhibit hepatitis B surface antigen (HBsAg) and hepatitis B e-antigen (HBeAg). The IC50 values of HBsAg and HBeAg were 4.02 mg/L and 5.19 mg/L, respectively. At the highest concentration of hydroxytyrosol, the inhibition rates of supernatant and intracellular HBV DNA were 75.99% and 66.33%, respectively. Hydroxytyrosol was less toxic to normal human hepatocytes. Molecular docking showed that hydroxytyrosol was bound to three amino acid residues of HBV polymerase with a binding energy of −7.0 kcal/mol. This study provided data for the development and utilization of Lindernia ruellioides and the research and development of anti-hepatitis B virus drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusPhenylethyl AlcoholAntiviral AgentsHumansMolecular Docking SimulationHep G2 CellsHepatitis B Surface AntigensHepatitis B e AntigensPlant ExtractsHepatocytesHepatitis B

Stichwörter der Autor:innen

Lindernia ruellioidesanti-hepatitis B virushydroxytyrosol

Substanzen

3,4-dihydroxyphenylethanolPhenylethyl AlcoholAntiviral AgentsHepatitis B Surface AntigensHepatitis B e AntigensPlant Extracts

Autor:innen und Institutionen

  • Key Laboratory of Molecular Medical Engineering, Education Department of Guangxi Zhuang Autonomous Region, Guilin Medical University, Guilin 541100, China.
  • College of Pharmacy, Guilin Medical University, Guilin 541100, China.
  • Key Laboratory of Medical Biotechnology and Translational Medicine, Education Department of Guangxi Zhuang Autonomous Region, Guilin Medical University, Guilin 541100, China.

ORCID-Profile: Jin-Tao Gao, Xian-Li Zhou

Förderung

  • the National Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, T. S., Li, K. Z., Su, H. L., Liang, B., Liang, C. Q., Gao, J. T., & Zhou, X. L. (2025). In Vitro Anti-Hepatitis B Virus Activity of Hydroxytyrosol from Lindernia ruellioides. Molecules. https://doi.org/10.3390/molecules30092063

Vancouver

Zhao TS, Li KZ, Su HL, Liang B, Liang CQ, Gao JT, et al. In Vitro Anti-Hepatitis B Virus Activity of Hydroxytyrosol from Lindernia ruellioides. Molecules. 2025. doi:10.3390/molecules30092063

BibTeX
@article{Zhao2025,
  author = {Zhao, Tong-Shi-Yao and Li, Kang-Zhi and Su, He-Ling and Liang, Bin and Liang, Cheng-Qin and Gao, Jin-Tao and Zhou, Xian-Li},
  title = {In Vitro Anti-Hepatitis B Virus Activity of Hydroxytyrosol from Lindernia ruellioides},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30092063}
}
Kostenlos starten →